The Claim
The Clinical Genome Resource (ClinGen) Curated Variant Curation Expert Panel for Creatine Deficiency Syndromes (CCDS VCEP) developed a points-based system to apply the PP4 criterion (specific phenotype) in variant pathogenicity assessment, using biochemical markers including urine and plasma guanidinoacetate and creatine levels, brain magnetic resonance spectroscopy (MRS) creatine levels, and enzyme or transporter activity in fibroblasts, with evidence strength graded from PP4_Supporting to PP4_Strong based on biomarker specificity.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A group of doctors created a scoring system to better figure out if certain gene changes cause creatine deficiency, using lab tests like blood, urine, brain scans, and skin cell tests — the more specific the test result, the stronger the evidence.
See the scientific wording
The CCDS VCEP implemented a points-based system for applying the PP4 criterion (specific phenotype) using biochemical markers such as urine and plasma guanidinoacetate and creatine levels, brain MRS creatine levels, and enzyme or transporter activity in fibroblasts, allowing for graded evidence strength from PP4_Supporting to PP4_Strong based on biomarker specificity.
What the research says
1 studyThe study shows that the expert group did create a scoring system using lab tests like blood and urine levels to judge how strong the evidence is for a genetic cause of a rare disorder, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.